Toxicity differences inform decision on conditioning for neuroblastoma transplants
MIAMI—The stem cell transplant regimen that was commonly used in the United States to treat advanced neuroblastoma in children appears to be more toxic than the equally effective regimen employed in Europe and Egypt, according ...
Apr 24, 2013
0
0